The SLC25A3 gene helps move phosphate into mitochondria, the parts of cells that make energy. If it does not work properly, cells may struggle to make enough energy, especially in muscles, the heart, and the brain. In medicine, this gene is important because it helps regulate energy supply in tissues with high demands. Pathogenic variants in the SLC25A3 gene can cause an inherited mitochondrial condition linked to muscle weakness, low muscle tone, an enlarged heart, breathing problems, and delayed development.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, which are the parts of cells that do much of the work. Others mainly help determine when certain processes take place, where they happen, and how strongly they run. Taken together, genes influence how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
SLC25A3Gene function
What if the gene works
The SLC25A3 gene helps move phosphate into mitochondria, the parts of cells that make energy. This supports ATP production, the cell’s main energy source, especially in tissues with high energy needs such as the heart and muscles.
Risk
What if the gene does not work
Variants in the SLC25A3 gene can reduce phosphate transport into mitochondria, limiting energy production. Depending on the variant, people may develop cardiomyopathy, muscle weakness, and high lactic acid levels, from early severe illness to milder later-onset forms.
Treatment
What does that mean for your treatment
No treatment or drug choice strategy specific to pathogenic variants in the SLC25A3 gene is currently established in clinical guidelines.
Conditions associated with SLC25A3
Gene function
What if the gene works
Your cells need a steady supply of energy to move, grow, and carry out routine repair. The SLC25A3 gene supports this daily work inside mitochondria, the parts of cells that make most of your energy. Understanding how the SLC25A3 gene works helps explain how your body turns nutrients into usable fuel.
The SLC25A3 gene helps move phosphate into mitochondria. Phosphate is a basic ingredient your cells need to make ATP, the main energy currency used throughout the body.
By supplying phosphate in the right place, the SLC25A3 gene helps mitochondria make energy from food. This is a central part of how the SLC25A3 gene supports normal cell function every day.
Cells use the SLC25A3 gene to keep energy production running in a controlled, reliable way. This supports routine tasks such as muscle movement, heart beating, and other constant energy needs.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC25A3 gene can alter the protein’s shape, stability, or transport activity, so less phosphate enters mitochondria and cells make less ATP, a form of energy. Some changes only partly reduce transport, while more severe variants can nearly stop it or cause the protein to break down. This is how SLC25A3 gene variants affect mitochondrial energy production. In established SLC25A3 disease, milder variants may be linked to later onset, while more disruptive variants often cause earlier, wider involvement.
How variants are linked to conditions
Pathogenic variants in the SLC25A3 gene cause a rare inherited mitochondrial condition often called mitochondrial phosphate carrier deficiency. This SLC25A3 gene condition is mainly linked to cardiomyopathy, muscle weakness, low muscle tone, high lactic acid levels, and breathing difficulties, usually starting in infancy or early childhood. Some people have a milder or later-onset form, but the strongest confirmed association is a mitochondrial disease affecting the heart and muscles.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the SLC25A3 gene. For many living with a disease-causing change in both copies of this gene, the main risk is largely set by the genetic change itself rather than lifestyle. Anyone with concerns about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of SLC25A3 variants
Variants in the SLC25A3 gene are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy from each parent, and the parents are often healthy carriers. When both parents carry an SLC25A3 gene variant, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier child, and a 25% chance of producing a child with two working copies. In families asking about the SLC25A3 inheritance pattern, sons and daughters are affected equally because this gene is on a non sex chromosome.
What does my SLC25A3 result mean for my family?
Changes in the SLC25A3 gene linked to disease are usually passed down in a recessive pattern, which often means parents are healthy carriers. For family members, this can mean brothers and sisters may also be affected or may be carriers, and other close relatives may carry the same gene change. A child of someone with an SLC25A3-related condition will usually be a carrier unless the other parent also carries a changed copy.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SLC25A3 variants usually checks DNA from a blood sample or cheek swab. A lab reads the SLC25A3 gene to look for variants that may help explain symptoms or confirm a diagnosis. Results may find a variant linked to disease, a harmless variant, or an unclear finding.
When should I consider getting a genetic test?
Testing for the SLC25A3 gene may be worth considering when someone has unexplained heart muscle disease, muscle weakness, low muscle tone, or serious energy problems that start in infancy or childhood. It can also help when these problems run in the family or when a close relative is known to carry an SLC25A3 variant.
A genetic result is only one part of your health story
Genetic test results can be informative, but how much they explain varies with the condition and the specific kind of variant. Over time, the way your body functions is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered together with other parts of care. In other situations, a genetic finding may give a clear answer. For topics like medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down or move a drug through the body differently, so the same treatment may work better for one person, have less effect in another, or cause more side effects in someone who is more sensitive. This kind of variation is common and is one reason medication response can differ from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It studies patterns between genes and drugs to help explain why the same treatment may work differently in different people. With many medications, genes influence how strong a drug’s effect is or how the body handles it. This information can support more informed, more personalized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC25A3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication use, so questions about side effects, new symptoms, or changes after starting a medicine are best discussed with your doctor.
History
SLC25A3 entered the genetics literature as researchers worked to identify the human genes behind the inner workings of mitochondria, the parts of cells that make energy. In the 1990s, scientists linked this gene to a long studied phosphate carrier in the mitochondrial membrane and clarified that it belonged to a larger family of transport genes. From these first observations, research expanded steadily. Later studies connected rare inherited variants in the SLC25A3 gene with conditions affecting muscle and heart function, which gave the gene clearer clinical importance. Over time, descriptions became more precise as genetic testing helped match specific SLC25A3 variants with patterns seen in affected families.